← All organizations
Highest phase reached
Phase 2
First clinical trial
May 1, 2005Last known activity
Jul 3, 2025
Timeline
1970s
- Jun 1, 1970
Northside Hospital, Inc.— Founded
Drugs by trial phase (30 distinct, 20 trials)
Indications
Studied for
- Anemia
- Anemia, Aplastic
- Graft vs Host Disease
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoproliferative Disorders
- Multiple Myeloma
- Myelodysplastic-Myeloproliferative Diseases
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Nausea
- Neoplasms
- Neoplasms, Plasma Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Syndrome
- Vomiting
Recent trials (39)
- NCT06828796Lead sponsorPhase 2Jul 3, 2025
- NCT06337331Lead sponsorPhase 2Aug 31, 2024
- NCT05909059Lead sponsorPhase 2Dec 31, 2023
- NCT06046248OfficialPhase 2Dec 31, 2023
- NCT06046248Lead sponsorPhase 2Dec 31, 2023
- NCT05909059CollaboratorPhase 2Dec 31, 2023
- NCT05519579Lead sponsorPhase 2Nov 1, 2022
- NCT05519579Overall official - principal investigatorPhase 2Nov 1, 2022
- NCT04408040Lead sponsorPhase 2Jun 30, 2020
- NCT04408040Overall official - principal investigatorPhase 2Jun 30, 2020
- NCT04237623Overall official - principal investigatorPhase 2Mar 15, 2020
- NCT04237623Lead sponsorPhase 2Mar 15, 2020
- NCT04235036Overall official - principal investigatorPhase 2Dec 16, 2019
- NCT04235036Lead sponsorPhase 2Dec 16, 2019
- NCT02771197Overall official - principal investigatorPhase 2Nov 1, 2016
Details
- Founded
- Atlanta, GA, US Jun 1, 1970
- Last known activity
- Jul 3, 2025